Cody Nesvick, MD, is an assistant professor of neurological surgery at the University of Pittsburgh and is surgical co-director of the Pediatric Skull Base Program and surgical director of the Neurovascular Center of Excellence at UPMC Children’s Hospital of Pittsburgh.
Originally from Tennessee, Dr. Nesvick completed medical school at the University of Tennessee Health Science Center in Memphis and a research fellowship at the National Institute of Health through the Medical Research Scholars Program. Following graduation, he completed his neurosurgical residency at Mayo Clinic, during which he also completed a three-year National Cancer Institute-funded post-doctoral research fellowship in neuro-oncology. Post-residency, Dr. Nesvick pursued further subspecialty training in pediatric neurosurgery at the Hospital for Sick Children (University of Toronto) and open and endoscopic skull-base oncology at Emory University.
In addition to his clinical practice, Dr. Nesvick heads the Applied Epigenomics Laboratory at the John G. Rangos, Sr. Research Center, where his team studies molecular mechanisms of tumorigenesis in atypical teratoid rhabdoid tumor (ATRT) and other pediatric brain tumors. As a surgeon-scientist, Dr. Nesvick’s vision is to provide the most comprehensive care for children with complex cranial disorders through technical excellence, cross-specialty collaboration and bench-to-bedside translational efforts.
Specialized Areas of Interest
Hospital Privileges
Professional Organization Membership
Education & Training
- BA, College Scholars, 2011
- NIH-HHMI Medical Research Scholars Program, National Institutes of Health, 2014
- Doctor of Medicine, University of Tennessee Health Sciences Center, 2016
- Residency, Neurological Surgery, Mayo Clinic, 2023
- NCI Fellowship, Neuro-Oncology (T32), Mayo Clinic, 2023
- Fellowship, Pediatric Neurosurgery, The Hospital for Sick Children, University of Toronto, 2024
- Fellowship, Skull-Base Oncology, Emory University, 2025
Honors & Awards
- Megan Rose Bradley Foundation Award, AANS Pediatric Section Meeting, 2021
- Scientific Showcase Top Abstract, Tumor/Neoplasms Panel, AANS Pediatric Section Meeting, 2020
Research Activities
Dr. Nesvick’s laboratory studies epigenetic mechanisms of disease in pediatric brain tumors, with a specific focus on atypical teratoid rhabdoid tumor (ATRT), a highly lethal brain and spinal cord cancer of very young children. Like many cancers, ATRT results from dysregulation of enhancers, which are key regions of the genome that must be activated for normal development. However, ATRT is highly unique in its molecular simplicity, and Dr. Nesvick’s work seeks to understand and exploit this feature to improve our understanding and better treat children with this disease.
His clinical research has two key objectives:
- To enhance surgical access to brain tumors in challenging locations by using advanced endoscopic endonasal surgery and minimally invasive neurosurgical techniques.
- To collaborate closely with neuro-oncologists, radiation oncologists and research teams to translate molecular insights into clinical action and improved patient outcomes. This includes playing key roles in national, multi-institutional clinical trial initiatives.